Cell cycle arrest and reversion of Ras-induced transformation by a conditionally activated form of mitogen-activated protein kinase kinase kinase 3

Molecular and Cellular Biology

Volumn 19, Issue 5, 1999, Pages 3857-3868

  Ellinger Ziegelbauer, Heidrun ^a   Kelly, Kathleen ^b   Siebenlist, Ulrich ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; FIBROBLAST; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RAT; REGULATORY MECHANISM;

ANIMALIA;

EID: 0032961833     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.5.3857     Document Type: Article

References (61)

1. Albanese, C., J. Johnson, G. Watanabe, N. Eklund, V. Dzuy, A. Arnold, and R. G. Pestell. 1995. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270: 23589-23597.
2. Billon, N., L. A. van Grunsven, and B. B. Rudkin. 1996. The cdk inhibitor p21WAF1/CIP1 is induced through a p300-dependent mechanism during NGF-induced neuronal differentiation of PC12 cells. Oncogene 13:2047-2054.
3. Blank, J. L., P. Gerwins, E. M. Elliott, Sather, and G. L. Johnson. 1996. Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. J. Biol. Chem. 271:5361-5368.
4. Brondello, J. M., F. R. McKenzie, H. Sun, N. K. Tonks, and J. Pouyssegur. 1995. Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts. Oncogene 10: 1895-1904.
5. Cohen, P. 1997. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol. 7:353-361.
6. Cox, A. D., and C. J. Der. 1994. Biological assays for cellular transformation. Methods Enzymol. 238:277-294.
7. Diehl, J. A., F. Zindy, and C. J. Sherr. 1997. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11:957-972.
8. Ellinger-Ziegelbauer, H., K. Brown, K. Kelly, and U. Siebenlist. 1997. Direct activation of the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by an inducible mitogen-activated protein kinase/ERK kinase kinase 3 (MEKK) derivative. J. Biol. Chem. 272:2668-2674.
9. 8a Ellinger-Ziegelbauer, H., and U. Siebenlist. Unpublished observations.
10. Fanger, G. R., P. Gerwins, C. Widmann, M. B. Jarpe, and G. L. Johnson. 1997. MEKKs, GCKs, MLKs, PAKs, TAKs, and Tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr. Opin. Genet. Dev. 7:67-74.
11. Gu, Y., J. Rosenblatt, and D. O. Morgan. 1992. Cell cycle regulation of cdk2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11:3995-4005.
12. Gum, R. J., M. M. McLaughlin, S. Kumar, Z. Wang, M. J. Bower, J. C. Lee, J. L. Adams, G. P. Livi, E. J. Goldsmith, and P. R. Young. 1998. Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB203580, by alteration of one or more amino acids within the ATP binding pocket. J. Biol. Chem. 273:15605-15610.
13. Herskowitz, I. 1995. MAP kinase pathways in yeast: for mating and more. Cell 80:187-197.
14. Ichijo, H., E. Nishida, K. Irie, P. ten Dijke, M. Saitoh, T. Moriguchi, M. Takagi, K. Matsumoto, K. Miyazono, and Y. Gotoh. 1997. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275:90-94.
15. Jiang, H., J. Lin, Z. Z. Su, F. R. Collart, E. Huberman, and P. B. Fisher. 1994. Induction of differentiation in human promyelocytic HL60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9:3391-3406.
16. Kahan, C., K. Seuwen, S. Meloche, and J. Poussegur. 1992. Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts, Evidence for thrombin-induced signals different from phosphoinositide turnover and adenylylcyclase inhibition. J. Biol. Chem. 267:13369-13375.
17. Kerkhoff, E., and U. R. Rapp. 1997. Induction of cell proliferation in quiescent NIH 373 cells by oncogenic c-Raf-1. Mol. Cell. Biol. 17:2576-2586.
18. King, R. W., R. J. Deshaies, J.-M. Peters, and M. W. Kirschner. 1996. How proteolysis drives the cell cycle. Science 274:1652-1659.
19. Kyriakis, J. M., and J. Avruch. 1996. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271:24313-24316.
20. MAPK pathway. J. Biol. Chem. 271:20608-20616.
21. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, J. R. Heys, S. W. Landvatter, J. E. Strickler, M. M. McLaughlin, I. R. Siemens, S. M. Fisher, G. P. Livi, J. R. White, J. L. Adams, and P. R. Young. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746.
22. Lin, A. W., M. Barradas, J. C. Stone, L. van Aelst, M. Serrano, and S. W. Lowe. 1998. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12: 3008-3019.
23. 1 progression in NIH 3T3 cells. Mol. Cell. Biol. 5:3654-3663.
24. Lucas, J., T. Herzinger, K. Hansen, M. C. Moroni, D. Resnitzky, K. Helin, S. I. Reed, and J. Bartek. 1997. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev. 11:1479-1492.
25. Lucas, J. J., A. Szepesi, J. F. Modiano, J. Domenico, and E. W. Gelfand. 1995. Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes. J. Immunol. 14:6275-6284.
26. Marshall, C. J. 1998. Taking the Rap. Nature 392:553-554.
27. Martin-Castellanos, C., and S. Moreno. 1997. Recent advances on cyclins, cdks and cdk inhibitors. Trends Cell Biol. 7:95-98.
28. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J.-Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
29. Meloche, S., K. Seuwen, G. Pages, and J. Poussegur. 1992. Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity. Mol. Endocrinol. 6:845-854.
30. Missero, C., E. Calautti, R. Eckner, J. Chin, L. H. Tsai, D. M. Livingston, and G. P. Dotto. 1995. Involvement of the cell cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. USA 92:5451-5455.
31. 1 to S phase cell cycle progression on both ras/mitogen-activated protein kinase and ras/racl/Jun N-terminal kinase cascades in NIH3T3 fibroblasts. J. Biol. Chem. 272:4904-4910.
32. 1/S through a mechanism requiring p38/RK. J. Biol. Chem. 272:13229-13235.
33. Morgan, D. O. 1995. Principles of cdk regulation. Nature 374:131-134.
34. mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90:8319-8323.
35. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer, helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
36. Peeper, D. S., T. M. Upton, M. H. Ladha, E. Neuman, J. Zalvide, R. Bernards, J. A. DeCaprio, and M. E. Ewen. 1997. Ras signalling linked to the cell cycle machinery by the retinoblastoma protein. Nature 386:177-181.
37. Poluha, W., C. M. Schonhoff, K. S. Harrington, M. B. Lachyankar, N. E. Crosbie, D. A. Bulseco, and A. H. Ross. 1997. A novel nerve growth factor-activated pathway involving nitric oxide, p53, and p21WAF1 regulates neuronal differentiation of PC12 cells. J. Biol. Chem. 271:24002-24007.
38. Racke, F. K., K. Lewandowska, S. Goueli, and A. Goldfarb. 1997. Sustained activation of the extracellular signal-regulated/mitogen-activated protein kinase is required for megakaryocyte differentiation of K562 cells. J. Biol. Chem. 271:23366-23370.
39. 1-to-S transition. Mol. Cell. Biol. 15:3463-3469.
40. KIP1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11:492-503.
41. Rohan, P. J., P. Davis, C. A. Moskaluk, M. Kearns, H. Krutzsch, U. Siebenlist, and K. Kelly. 1993. Pac-1: a mitogen-induced nuclear protein tyrosine phosphatase. Science 259:1763-1766.
42. Roussel, M. F., A. M. Theodoras, M. Pagano, and C. J. Sherr. 1995. Rescue of defective mitogenic signaling by D-type cyclins. Proc. Natl. Acad. Sci. USA 92:6837-6841.
43. Samuels, M. L., M. J. Weber, J. M. Bishop, and M. McMahon. 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human Raf-1 protein kinase. Mol. Cell. Biol. 13:6241-6252.
44. Seger, R., and E. G. Krebs. 1995. The MAPK signaling cascade. FASEB J. 9:726-735.
45. Sewing, A., C. Buerger, S. Bruesselbach, C. Schalk, F. C. Lucibello, and R. Mueller. 1993. Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. J. Cell Sci. 104:545-554.
46. Cip1. Mol. Cell. Biol. 17:5588-5597.
47. 2-terminal kinase groups of mitogen-activated protein kinases. J. Biol. Chem. 271:5750-5754.
48. 1 cyclins. Cell 73:1059-1065.
49. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1652.
50. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
51. Stein, G. H., and V. Dulic. 1995. Origins of G1 arrest in sensecent human fibroblasts. Bioessays 17:537-543.
52. Steinman, R. A., B. Hoffman, A. Iro, C. Guillouf, D. A. Liebermann, and M. E. el-Houseini. 1994. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9:3389-3396.
53. kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol. 17:5348-5358.
54. Tibbles, L. A., Y. L. Ing, F. Kiefer, J. Chan, N. Iscove, J. R. Woodgett, N. J., and Lassam. 1996. MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. EMBO J. 15:7026-7035.
55. Walsh, K., and H. Perlman. 1997. Cell cycle exit upon myogenic differentiation. Curr. Opin. Genet. Dev. 7:597-602.
56. Watanabe, G., R. J. Lee, C. Albanese, W. E. Rainey, D. Batle, and R. G. Pestell. 1996. Angiotensin II activation of cyclin D1-dependent kinase activity. J. Biol. Chem. 271:22570-22577.
57. 1 phase. Biochem. J. 326:61-68.
58. Cip1. Mol. Cell. Biol. 17:5598-5611.
59. Yan, G. Z., and E. B. Ziff. 1995. NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1. J. Neurosci. 15:6200-6212.
60. Zetterberg, A., and O. Larsson. 1985. Kinetic analysis of the regulatory events in G1 leading to proliferation or quiescence of Swiss 3T3 cells. Proc. Natl. Acad. Sci. USA 82:5365-5469.
61. Zhu, J., D. Woods, M. McMahon, and J. M. Bishop. 1998. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12:2997-3007.